Chargement en cours...
Protease inhibitors for the treatment of hepatitis C virus infection
The hepatitis C virus (HCV) has affected an estimate of 80 million individuals worldwide and is a strain of public health. Around 25–30% of patients in Europe and the US infected with HIV are coinfected with HCV. Despite treatment modalities containing a NS3/4A protease inhibitor in combination with...
Enregistré dans:
| Publié dans: | GMS Infect Dis |
|---|---|
| Auteurs principaux: | , |
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
German Medical Science GMS Publishing House
2017
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6301719/ https://ncbi.nlm.nih.gov/pubmed/30671330 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3205/id000034 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|